MENU
ELTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Elicio Therapeutics (ELTX) Ownership - Who owns Elicio Therapeutics?

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes... Show more

Profile

Industry
N/A
Address
451 D Street
Phone
+1 857 209-0050
Employees
32
Web
https://www.elicio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
141.35M
P/E Ratio
5.96
Total Cash
20.61M
Projected Growth
N/A
Total Debt
15.06M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.19
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

ELTX
Capitalization
141M
P/E Ratio
5.96
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
20.6M
Total Cash/Share
1.19
Total Debt
15.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.82M
P/B Ratio
37.04
Cash Flow
N/A
Earnings
-3.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
173K
Current Ratio
3.29
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-43.68M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-137.56
Shares Held By Institutions
24.6M
Shares Outstanding - Current
17.3M
Total Liabilities
24.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
60.588
View a ticker or compare two or three
ELTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
451 D Street
Phone
+1 857 209-0050
Employees
32
Web
https://www.elicio.com